Redpoint Investment Management Pty LTD Alnylam Pharmaceuticals, Inc. Transaction History
Redpoint Investment Management Pty LTD
- $684 Million
- Q3 2022
A detailed history of Redpoint Investment Management Pty LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 2,921 shares of ALNY stock, worth $849,134. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,921
Previous 2,490
17.31%
Holding current value
$849,134
Previous $363,000
61.16%
% of portfolio
0.09%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
671Shares Held
108MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.83 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.7 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.78 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$2.03 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.27 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $35.8B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...